Other studies have shown that upon treatment of estrogen, multidrug-resistant ER-α-positive breast cancer cells downregulate P-gp but not ABCB1 RNA [121,122], suggesting a post-transcriptional mechanism of regulation. The gene discussed is ESR1; the disease is breast carcinoma.